KDR and neoplasm: This small molecule inhibits the vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and RAF, thereby decreasing tumor cell proliferation and angiogenesis while simultaneously promoting apoptosis of tumor cells.